Supply chain, logistics

Genixus adds manufacturing facility for syringe production

16-Mar-2023 By Ben Hargreaves

The company will build out a manufacturing, warehousing, and distribution center in the US to expand capacity for syringes.

Assentia launches tech platforms to support payments in the clinical trial space

14-Mar-2023 By Ben Hargreaves

The company releases two SaaS-based applications, GrantPay and GrantPact, to provide clinical trial contract negotiation and payment services.

EQRx backtracks on plans to reduce pricing of lead cancer treatments

21-Nov-2022 By Ben Hargreaves

For its two lead oncology programs, the company will pursue “market-based pricing”, moving away from plans to “dramatically lower prices” for treatments.

Medisca announces plans for distribution and packaging center

07-Nov-2022 By Ben Hargreaves

The facility will comprise of a standalone building to consolidate repackaging and distribution operations in the state of New York, US.

McKesson opens largest distribution facility in its network

03-Nov-2022 By Ben Hargreaves

The company officially unveils its pharmaceutical distribution center that is based in Jeffersonville, Ohio.

CPHI Pharma Award finalists announced

26-Oct-2022

The awards cover innovations spanning the full pharmaceutical supply chain and feature many of pharma’s biggest names and breakthrough companies.

Industry body points to ‘clear and serious threat’ to clinical research in UK

26-Oct-2022 By Ben Hargreaves

The ABPI releases a report that shows the number of clinical trials taking place in the UK fell by a large amount between the years 2017 and 2021.

FDA announces Adderall supply has been hit by manufacturing issues

18-Oct-2022 By Ben Hargreaves

According to the agency, Teva communicated that it would have difficulties supplying immediate release formulations of the drug due to manufacturing delays.

Gilead takes legal fight to ‘kingpins’ of counterfeit HIV medicine

04-Oct-2022 By Ben Hargreaves

The company announces further measures against a counterfeiting network it accused of being responsible for selling illegitimate Gilead HIV medications.

Takeda signs 12-year renewable energy agreement in US

26-Sep-2022 By Ben Hargreaves

Adding to broader action being taken across the industry, the company has signed an agreement with Enel for the supply of renewable energy credits covering its electricity needs across the US.

Market demands, trends impacting APIs and excipients: MilliporeSigma

31-Aug-2022 By Jenni Spinner

An expert from the company discusses how ever-changing patient needs and other dynamic factors are likely to impact pharma ingredient trends down the road.

Synthetic bio company Antheia raises $40m, announces new pilot plant

31-Aug-2022 By Jenni Spinner

The synthetic biology company which specializes in producing ingredients for plant-inspired medicines has a pilot-scale manufacturing facility in the works.

New WuXi STA plant to tackle growing HPAPI demand

31-Aug-2022 By Jenni Spinner

A company leader advises that the growing need for high-potency active pharmaceutical ingredients calls for CDMOs that consistently deliver quality at scale.

Outsourcing strategists thinking farther ahead than ever: CPHI

23-Aug-2022 By Jenni Spinner

The group’s latest report glimpses inside the minds of pharma leaders, who are looking at a product’s full life-cycle development at the preclinical stage.

Tech Innovations: August 2022

22-Aug-2022 By Jenni Spinner

This month’s news on technology, partnerships, expansions, and more includes items from IQVIA, Almac Group, Signant Health, Lonza, and other key companies.

Signant turns to Loftware for clinical supply chain management support

15-Aug-2022 By Nick Taylor

Signant Health has partnered with the software company o connect its platforms for the management of clinical supply chain inventory, labels, and content.

UPS acquires multi-national healthcare logistics company Bomi

15-Aug-2022 By Jenni Spinner

The purchase brings under the UPS Healthcare umbrella several temperature-controlled facilities in 14 countries situated throughout Europe and Latin America.

Novasep-PharmaZell commits nearly$7.5m to boosting API capacity

01-Aug-2022 By Jenni Spinner

The contract development and manufacturing organization plans to invest €7.3m to expand and upgrade API production capacity at its Mourenx, France facility.

Will biotech see an uptick in M&A?

19-Jul-2022 By Rachel Arthur

The biopharma M&A market has slowed since 2019. But is a buyer’s market emerging?

Piramal Pharma Solutions opens doors on API production plant

13-Jul-2022 By Jenni Spinner

The contract development and manufacturing organization's active pharmaceutical ingredient manufacturing operation is located at its site in Aurora, Canada.

Vetter kicks off operations at fill-and-finish facility in Austria

13-Jul-2022 By Jenni Spinner

The contract development and manufacturing organization has begun fulfilling customer orders at its new clinical manufacturing facility in Rankweil, Austria.

On-demand cleanrooms help pharma manufacturers ‘fail fast’

13-Jul-2022 By Jenni Spinner

A representative from life-science services company Azzur Group explains how flexibility and speed can help in reaching the best solution more efficiently.

People on the Move: July 2022

11-Jul-2022 By Jenni Spinner

This month’s announcements of launches, appointments, and partnerships includes Saama, COTA, Yourway, Eversana, Kindeva, and other notable industry companies.

Building resilience into biotech supply chains: 'COVID-19 will not be the last major crisis of the 21st century'

08-Jul-2022 By Rachel Arthur

Biotech supply chains face an uncertain future in 2022 and beyond: up against myriad challenges ranging from future pandemic outbreaks to geopolitical tensions – and, indeed, unforeseen threats. Communication and collaboration between policymakers and...

EY biotech report checks in on the mood of industry leaders

23-Jun-2022 By Jenni Spinner

The 32nd iteration of the company’s Beyond Borders report offers an in-depth look at the state of the current market landscape, and what’s on the horizon.

BIO research outlines risks in changing accelerated approval pathway

21-Jun-2022 By Rachel Arthur

If new restrictions are placed on the FDA’s Accelerated Approval pathway, as many as two thirds of the treatments that use this pathway would never reach patients, according to research released at the BIO International Convention last week.

Tech Innovations: June 2022

16-Jun-2022 By Jenni Spinner

This month’s announcements on new products, enhanced technology, partnerships, and more includes Eversana, Thermo Fisher Scientific, and other notable companies.

bio 2022

Pandemic highlights need for supply chain visibility, partnerships

14-Jun-2022 By Jenni Spinner

During BIO International, US leaders shared lessons learned from COVID-19, and how government and industry are collaborating to avoid future supply chain crises.

bio 2022

ten23 adds manufacturing building in rapid build out

14-Jun-2022 By Ben Hargreaves

The newly launched CDMO plans to set up two new manufacturing lines, after expanding into a 5,000-square-meter manufacturing facility.

dia 2022

Collaboration, innovation to take center stage at DIA 2022

08-Jun-2022 By Jenni Spinner

This year’s DIA Global Annual Meeting (taking place June 19-23 in Chicago) reunites professionals for face-to-face learning and networking opportunities.

Building in resilience can protect against disruption: Rockwell

08-Jun-2022 By Jenni Spinner

An expert from Rockwell Automation explains how integrating flexibility, using advanced technology, can help pharma manufacturing operations weather a storm.

Lilly invests $2.1bn in new Indiana manufacturing sites

31-May-2022 By Rachel Arthur

Eli Lilly and Company plans to expand its manufacturing footprint in Indiana by investing $2.1bn in two new manufacturing sites at Indiana's LEAP Lebanon Innovation and Research District in Boone County.

Novartis looks to work more strategically as CDMO

16-May-2022 By Jane Byrne

Novartis has recently set up a new contract development and manufacturing unit called Global Biotech Co-operations (GBTC).

Survey: industry leaders looking to shore up pharma supply chain

05-May-2022 By Jenni Spinner

According to the 2022 EY CEO survey, life science executives are seeking to build resilience into their supply chains and dive into M&A opportunities.

CPHI North America

Future drugs will need novel excipients: IPEC

04-May-2022 By Jenni Spinner

An expert from the organization discusses ahead of his CPhI North America presentation how tomorrow’s drugs can’t all be formulated with yesterday’s excipients.

CPhI North America 2022

Continuous manufacturing adoption continues to rise: Pharmatech

04-May-2022 By Jenni Spinner

An expert from Pharmatech Associates offers a glimpse into the evolution of CM and previews a lively discussion during the upcoming CPhI North America event.

CPhI North America 2022

Pharma growth, partnerships focus of 2022 CPhI North America

04-May-2022 By Jenni Spinner

A leader from the organizer of the pharmaceutical event discusses what’s in store for the upcoming conference, and for the drug development industry itself.

CPHI NORTH AMERICA 2022

US pharma hubs: The rising stars to watch

04-May-2022 By Rachel Arthur

CPhI North America 2022 host city Philadelphia is set to become one of the world’s biggest cell and gene therapy manufacturing hubs. But it’s just one of many centers of innovation that are helping drive the US pharma and biopharma industry.

Proposed bill aims to encourage US pharmaceutical manufacturing

03-May-2022 By Jenni Spinner

Introduced by two Republican Congressmen, the American Made Medicine Act is intended to boost domestic drug manufacturing and create jobs in the sector.

Yourway adds 100k square feet of temp-controlled storage capacity

28-Apr-2022 By Jenni Spinner

The addition of the facility in Pennsylvania will help meet the increasing demand for temperature-controlled clinical packaging, storage, and distribution.

HPAPI Summit hones in on pharmaceutical manufacturing risk

25-Apr-2022 By Jenni Spinner

The 2022 edition of the Highly Potent Active Pharmaceutical Ingredients Summit (June 28 to 30 in Boston) will take on a range of topics, including safety.

Catalent to invest $350m to expand US drug substance and product manufacturing site

22-Apr-2022 By Jane Byrne

Catalent has announced a multi-year $350m investment at its facility in Bloomington, Indiana, to expand biologics drug substance and drug product manufacturing capabilities.

Lonza expands API development capacity at Nansha, China plant

21-Apr-2022 By Jenni Spinner

The pharma manufacturing specialist is increasing capacity at its development and manufacturing labs to meet growing global demand for highly potent APIs.

Inke to triple capacity for inhalation API manufacturing

20-Apr-2022 By Jenni Spinner

The maker of active pharmaceutical ingredients for inhaled treatments is investing €9m ($9.8m USD) to expand its manufacturing plant in Barcelona, Spain.

Cryoport buys French biostorage and logistics specialist

19-Apr-2022 By Jane Byrne

Cryoport Inc has acquired Cell&Co BioServices, continuing its EMEA expansion efforts.

People on the Move: April 2022

11-Apr-2022 By Jenni Spinner

This month’s news includes hiring, promotions, expansions, and acquisitions at H Clinical, Charles River, DHL Supply Chain, X-Chem, and other key companies.

PharmaZell, Novasep merger creates new CDMO, API manufacturer

07-Apr-2022 By Jenni Spinner

The union of the active pharmaceutical ingredient supplier and contract development and manufacturing organization will create a global services company.

Pharma supply chain could learn from the food industry: Rephine

04-Apr-2022 By Jenni Spinner

An executive from Rephine Catena discusses how pharmaceutical companies dealing with supply chain challenges could draw lessons from the food industry.

Ukraine war offers hard lessons for clinical research industry: H1

29-Mar-2022 By Jenni Spinner

A leader from the healthcare technology company discusses the conflict’s impact on the region and beyond and the need to better guard against interruptions.

Pfizer to supply up to 4m COVID-19 treatment courses to UNICEF

22-Mar-2022 By Jenni Spinner

The pharmaceutical company has agreed to provide its Paxlovid oral COVID-19 treatment to the global charity, covering 95 low- and middle-income countries.